CHENGDU, China, Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ: BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase ...

. In this article, we are going to take a look at where BGM Group Ltd. (NASDAQ:BGM) stands against the other AI stocks. AI is transforming industries by enabling machines to learn, adapt, and make ...

BGM Group Ltd. is a pharmaceutical and chemical company. It focuses on the research, development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional ...

CHENGDU - BGM Group Ltd (NASDAQ: BGM), a $947 million market cap company with a strategic focus on technology and biopharmaceuticals, has announced a significant reshuffle of its board of ...

The Chinese pharmaceutical company BGM Group Ltd. has completed the acquisition of the intelligent insurance platform AIX Inc. for $140 million. This is reported in the BGM press release. As part of ...

CHENGDU - BGM Group Ltd (NASDAQ: BGM), a $947 million market cap company with a strategic focus on technology and biopharmaceuticals, has announced a significant reshuffle of its board of directors as ...